Does Black Cohosh Cause Cancer?
Black cohosh does not cause cancer and appears to be safe for use in women with breast cancer, with some evidence suggesting it may actually reduce breast cancer risk and recurrence. 1, 2
Key Evidence on Cancer Risk
The most reassuring data comes from observational studies showing black cohosh is associated with reduced cancer risk rather than increased risk. Specifically, postmenopausal women using black cohosh had a 53% reduction in primary breast cancer risk (adjusted OR = 0.47) and a 25% reduction in recurrence risk (adjusted HR = 0.75) 3. This protective effect is supported by multiple lines of evidence:
Lack of Estrogenic Activity
The primary concern about black cohosh has been its potential estrogenic effects on hormone-sensitive tissues. However, guideline-level evidence clearly demonstrates black cohosh does not exhibit estrogenic activity 2:
- No estrogen receptor (ER) binding
- No upregulation of estrogen-dependent genes
- No stimulation of estrogen-dependent tumor growth in animal models 2
- No effect on circulating hormone levels or proliferation in estrogen-responsive tissues 3
- No breast-specific estrogenic effects on cellular morphology or pS2 expression 4
Clinical Safety in Breast Cancer Patients
Guidelines from the American Association of Clinical Endocrinologists (2011) specifically note that concerns about black cohosh's estrogenicity "seem to be allayed" by the absence of ER binding and tumor stimulation 2. Multiple clinical trials in breast cancer survivors showed no adverse effects on cancer outcomes 3, 5.
Important Caveats and Contradictory Evidence
Metastatic Potential - A Critical Warning
One concerning animal study found that black cohosh significantly increased lung metastases in tumor-bearing mice expressing c-erbB2/HER2+ 6. While this did not affect primary tumor development, it raises questions about use in women with existing HER2+ breast cancer. This is the only study showing potential harm, but it addresses the critical outcome of metastatic progression and mortality.
Hepatotoxicity Risk
The more established safety concern is liver toxicity, not cancer 1, 7. Multiple case reports document hepatitis and even liver failure with black cohosh use 1. Guidelines recommend:
Conflicting Laboratory Data
Some in vitro studies show estrogenic effects and increased ER levels in breast cancer cells 8, while others demonstrate anti-estrogenic and antiproliferative effects 9. The clinical data consistently shows no estrogenic effects, suggesting the in vitro findings may not translate to human use 3, 5, 4.
Clinical Recommendations
For women concerned about cancer risk:
- Black cohosh does not increase cancer risk and may be protective
- It can be used safely in breast cancer survivors, including those on tamoxifen 10
- The primary safety concern is hepatotoxicity, not cancer
Practical limitations:
- Limit use to 6 months due to lack of long-term safety data 2
- Avoid in women with liver disease
- Exercise caution in women with HER2+ breast cancer given the single metastasis study 6
- Note that black cohosh is ineffective for hot flashes compared to placebo in most trials 1
The evidence hierarchy strongly favors safety: Guidelines 1, 2, systematic reviews 3, 5, and clinical trials consistently show no cancer-promoting effects, with observational data suggesting protection. The single concerning animal study 6 is outweighed by human clinical evidence but warrants mention for informed decision-making, particularly regarding metastatic disease.